GLI1 and skin basal cell carcinoma: While non- aggressive human BCC subtypes display high NEO1 expression, aggressive human BCC subtypes present with lower levels of NEO1, similar to GLI1, suggesting a possible role of SHH/GLI/NEO1 signaling in tumor aggressiveness.